Project Grant R43GM142252
Award Date
5/1/21
Completion Date
10/31/21
Dollars Obligated
$659K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
Partillion Bioscience Corp received a $255,916 Project Grant award from the National Science Foundation on September 1, 2021 to support work concluding May 31, 2022. The grant is part of NSF's Engineering program (CFDA 47.041), which aims to improve quality of life and economic strength through engineering research and innovation. Specifically, the award funds development of microparticle reagents for clonal selection of producer cell lines. This work advances the NSF Engineering program's goals...
This Project Grant award, issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,000,000 in funding to Partillion Bioscience Corp, a for-profit biotechnology company in Los Angeles, California. The award supports the development of advanced workflows utilizing Partillion's specialized hydrogel microparticle technology, called "nanovials", to enable ultra high-throughput...
This $349,816 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) aims to develop a prototype instrument, software, and consumable for non-invasive identification, tagging, and downstream characterization of live cells. The product will enable researchers to study clinically relevant cell-cell interactions, which drive many challenging diseases like cancer, autoimmunity, and neurological disorders....
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) aims to develop a new microfluidic/nanofluidic sample preparation platform to improve single-cell and low-input proteomics analysis. The $350,000 award to Fluidispec LLC in Philadelphia, PA will fund fundamental studies on the protein purification process and measurement of anticipated improvements in both top-down and bottom-up...
The National Institute of General Medical Sciences (NIGMS) awarded a $283,805 Project Grant under CFDA 93.859 (Biomedical Research and Research Training) to Invizyne Technologies, Inc., a small disadvantaged business based in Monrovia, California. The project, titled "BIO-CLICK: A CELL-FREE HIGH-THROUGHPUT PLATFORM FOR THE ENGINEERING OF ENZYMATIC GROUP TRANSFER REACTIONS", focuses on developing a novel cell-free, high-throughput platform to expedite the engineering of enzymes for...
The National Institute of General Medical Sciences (NIGMS) awarded a $333,048 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to Imagen Bioworks Inc. in Houston, TX. The objective of this 1-year project is to develop a versatile 2-photon microscopy-based platform, dubbed "2P-Spotlight," that can isolate individual cells from 3D tissue samples after spatiotemporal profiling. This will address a critical limitation of current single-cell...
This $295,924 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) aims to develop and demonstrate a high-yield microfluidic device for the enrichment and capture of CD3+ T cells. This device is intended to improve the manufacturing of autologous and allogenic engineered cell therapies such as CAR-T, which currently have time-consuming and costly production processes. The key objectives are to (1)...
This National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) Project Grant award of $613,746 to Osem Fluidics Inc. aims to develop 3D-printed microfluidic channel architectures to precisely control the structure and properties of lipid nanoparticles (LNPs) for enhanced nucleic acid delivery. The research focuses on designing, simulating, and testing various 3D channel configurations to manipulate flow conditions and tailor LNP...
The federal Project Grant award for $1,965,880.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support the development and commercialization of an integrated, multifunctional "smart Petri dish" that uses acoustic tweezers technology to precisely manipulate cells and other bioparticles. The award, spanning June 2024 to May 2026, will enable Ascent Bio-Nano Technologies, Inc., a minority-owned,...
The National Institute of General Medical Sciences (NIGMS) awarded a $358,862 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to GMJ Technologies, Inc., a minority-owned small business, to develop a microfluidic SDS depletion electrophoresis (SDE) interface. This interface will enable direct coupling of capillary electrophoresis with sodium dodecyl sulfate (CE-SDS) to mass spectrometry for improved characterization and quality control of monoclonal...